, a bio/informatics shared resource is still "open for business" - Visit the CDS website

Zambian women's attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV.

Sinkala M, Stout JP, Vermund SH, Goldenberg RL, Stringer JS
Lancet. 2001 358 (9293): 1611-2

PMID: 11716891 · DOI:10.1016/S0140-6736(01)06662-4

Use of mass nevirapine therapy--universal provision of the drug without HIV testing--for prevention of perinatal HIV in high prevalence settings with extreme resource constraints is a controversial strategy. A quarter of pregnant Zambian women surveyed would prefer to receive nevirapine through a non-testing mass strategy, and most would support mass therapy as a policy if it would make the drug available to a larger proportion of the at-risk population.

MeSH Terms (10)

Anti-HIV Agents Attitude to Health Female HIV Infections Humans Infectious Disease Transmission, Vertical Nevirapine Pregnancy Surveys and Questionnaires Zambia

Connections (1)

This publication is referenced by other Labnodes entities: